CB units with A and B haplotypes showed the same rate of dominance and CB units with specific telomeric or centromeric haplotype B motifs did not show a dominance advantage. We then analyzed the frequency distribution of each activating KIR in both units. CB units possessing any one of the activating KIRs did not show a higher chance of dominance. In addition, units lacking all activating KIRs were not less likely to dominate. Of the activating KIRs, only KIR2DS1 has class I specificity; we could not demonstrate that KIR2DS1-positive units with an HLA-C1 background were more likely to dominate if the second unit possessed HLA-C2. According to the inhibitory KIR genotype and the presence or absence of HLA class I ligands in the CB units and the recipients, different KIR and HLA interactions predictive of a 'missing ligand' or 'missing self' effect were evaluated. To determine the role of HLA and KIR genotypes in unit-unit interaction and single-unit dominance, we investigated the hypothesis that a CB unit fails to dominate if it lacks HLA class I ligand for an individual inhibitory KIR present in the second unit (missing ligand) or if it lacks HLA class I determinants present in the second unit (missing self). We divided the CB unit pairs into four categories depending on whether none, one or both units are missing HLA KIR ligands or self-antigens for the other unit's inhibitory KIR. KIR-HLA interactions predictive of NK allo-reactivity between CB units in a unidirectional manner did not predict unit dominance. To determine the role of HLA and KIR genotypes in unit-recipient interaction and single-unit dominance we investigated two different hypotheses: (1) a CB unit is more likely to dominate if the recipient lacks HLA class I ligand for a specific inhibitory KIR present in the unit (missing ligand) or lacks HLA class I determinants present in the unit (missing self); or (2) a CB unit is less likely to dominate if it lacks HLA class I ligand for a specific inhibitory KIR present in the recipient (missing ligand) or lacks HLA class I determinants present in the recipient (missing self). The CB unit pairs were divided into different categories depending on whether the recipient lacked HLA ligands or self-antigens for neither, one or both units' inhibitory KIR, or, if neither, whether one or both units lacked the HLA ligand or self-antigens for the recipient's inhibitory KIR. A chi-square test for equal distribution demonstrated that CB units did not have a higher likelihood of dominance if the patient was missing ligands or lacked class I determinants present in either unit. Similarly, CB units missing the KIR ligand or lacking class I determinants present in the recipient did not have a lower rate of dominance.
In this cohort of 83 double-unit CBT recipients, we failed to find an association between KIR and HLA genotypes with unit dominance. However, our small sample size and the limited number of CB pairs with unilateral NK alloreactivity may have precluded us in finding an association if one exists. The role of KIR and HLA genotypes in unit dominance still cannot be excluded and larger studies investigating this question are warranted. Both units missing self (n = 11) Neither unit missing self (n = 43) Abbreviation: CBT = cord blood transplantation. KIR haplotype B and the presence of one or more activating KIR were not associated with CB unit dominance. KIR/HLA genotypes in unit-unit and unit-recipient interactions were not associated with CB unit dominance.
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